• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » A*STAR, Sumitomo Mitsui Banking ink MOU for Japanese R&D in Singapore

A*STAR, Sumitomo Mitsui Banking ink MOU for Japanese R&D in Singapore

August 20, 2014
CenterWatch Staff

The Singapore-based Agency for Science, Technology and Research (A*STAR) and Japan-based Sumitomo Mitsui Banking Corporation (SMBC) have inked a memorandum of understanding (MOU), with the aim of supporting Japanese R&D activities in Singapore for the next three years.

The partnership not only will promote scientific and technological research activities in Singapore, but also will strengthen SMBC’s value proposition to its Japanese customers who are looking to globalize their business.

Masayuki Shimura, managing director and head of Asia Pacific Division, SMBC, said, “Singapore is a choice location for companies aspiring to develop and optimize their products to cater to the unique characteristics of the expanding markets in Southeast Asia, India and Oceania.”

A*STAR provides a unique infrastructure that is conducive to interactions and collaborations across institutes and disciplines through its activities centered in Biopolis and Fusionoplis, Singapore’s twin research hubs for biomedical and engineering research. By providing intellectual, human and industrial capital to its partners in industry, A*STAR supports Singapore's key economic clusters. It also engages in collaborations with academia and industry to support a vibrant system of generating new ideas and innovations.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing